These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 8056004)

  • 21. Early and late effects of rt-PA vs placebo on left ventricular function measured by nuclear ventriculography.
    Mortelmans L; Scheys I; Brzostek T; Lesaffre E; De Roo M; Verstraete M; De Geest H; Van de Werf F
    Nuklearmedizin; 1993 Jun; 32(3):120-7. PubMed ID: 8327330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A double blind placebo controlled study of early and late administration of recombinant tissue plasminogen activator in acute myocardial infarction.
    McNeill AJ; Cunningham SR; Flannery DJ; Dalzell GW; Wilson CM; Campbell NP; Khan MM; Patterson GC; Webb SW; Adgey AA
    Br Heart J; 1989 Apr; 61(4):316-21. PubMed ID: 2496740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early spontaneous intermittent myocardial reperfusion during acute myocardial infarction is associated with augmented thrombogenic activity and less myocardial damage.
    Haider AW; Andreotti F; Hackett DR; Tousoulis D; Kluft C; Maseri A; Davies GJ
    J Am Coll Cardiol; 1995 Sep; 26(3):662-7. PubMed ID: 7642856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Left ventricular function as an end-point of thrombolytic therapy.
    Norris RM; White HD
    Eur Heart J; 1990 Aug; 11 Suppl F():5-9. PubMed ID: 2121490
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of thrombolytic therapy administered 6 to 24 hours after myocardial infarction on the signal-averaged ECG. Results of a multicenter randomized trial. LATE Ancillary Study Investigators. Late Assessment of Thrombolytic Efficacy.
    Steinberg JS; Hochman JS; Morgan CD; Dorian P; Naylor CD; Theroux P; Topol EJ; Armstrong PW
    Circulation; 1994 Aug; 90(2):746-52. PubMed ID: 8044943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Left ventricular function and cardiovascular events following adjuvant therapy with adenosine in acute myocardial infarction treated with thrombolysis, results of the ATTenuation by Adenosine of Cardiac Complications (ATTACC) study.
    Quintana M; Hjemdahl P; Sollevi A; Kahan T; Edner M; Rehnqvist N; Swahn E; Kjerr AC; Näsman P;
    Eur J Clin Pharmacol; 2003 May; 59(1):1-9. PubMed ID: 12743668
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thrombolysis and coronary occlusion: effects upon the non-infarct zone.
    Cranswick R; Carter G; Wilkes N; Nelson G
    Eur Heart J; 1992 Jun; 13(6):770-5. PubMed ID: 1623865
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tissue plasminogen activator: Toronto (TPAT) placebo-controlled randomized trial in acute myocardial infarction.
    Armstrong PW; Baigrie RS; Daly PA; Haq A; Gent M; Roberts RS; Freeman MR; Burns R; Liu P; Morgan CD
    J Am Coll Cardiol; 1989 Jun; 13(7):1469-76. PubMed ID: 2498414
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of If-channel inhibition on hemodynamic status and exercise tolerance in heart failure with preserved ejection fraction: a randomized trial.
    Kosmala W; Holland DJ; Rojek A; Wright L; Przewlocka-Kosmala M; Marwick TH
    J Am Coll Cardiol; 2013 Oct; 62(15):1330-8. PubMed ID: 23916925
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [t-PA in thrombolytic therapy of acute myocardial infarct].
    Rutsch W; Schmutzler H
    Herz; 1994 Dec; 19(6):336-52. PubMed ID: 7843690
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rescue thrombolysis: alteplase as adjuvant treatment after streptokinase in acute myocardial infarction.
    Mounsey JP; Skinner JS; Hawkins T; MacDermott AF; Furniss SS; Adams PC; Kesteven PJ; Reid DS
    Br Heart J; 1995 Oct; 74(4):348-53. PubMed ID: 7488444
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dose-ranging study with a new two-chain rt-PA in patients with acute myocardial infarction: a multicenter trial.
    DeWood MA; Kurnik PB; Jolly MK; Jain AC; Khaja F; Gorfinkel HJ; Morris DL; Satler L; LittleJohn J
    Clin Cardiol; 1993 Apr; 16(4):302-10. PubMed ID: 8458110
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Left ventricular diastolic performance at rest is essential for exercise capacity in patients with non-complicated myocardial infarction.
    Dekleva MN; Mazic SD; Suzic-Lazic JM; Marković-Nikolić NS; Beleslin BD; Stevanović AM; Djelic MN; Arandjelović AM
    Heart Lung; 2014; 43(6):500-5. PubMed ID: 24928183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS).
    Hacke W; Kaste M; Fieschi C; Toni D; Lesaffre E; von Kummer R; Boysen G; Bluhmki E; Höxter G; Mahagne MH
    JAMA; 1995 Oct; 274(13):1017-25. PubMed ID: 7563451
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential effects of tissue plasminogen activator and streptokinase on infarct size and on rate of enzyme release: influence of early infarct related artery patency. The GUSTO Enzyme Substudy.
    Baardman T; Hermens WT; Lenderink T; Molhoek GP; Grollier G; Pfisterer M; Simoons ML
    Eur Heart J; 1996 Feb; 17(2):237-46. PubMed ID: 8732377
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mortality and morbidity 1 year after early thrombolysis in suspected AMI: results from the TEAHAT Study.
    Herlitz J; Dellborg M; Hartford M; Karlsson T; Risenfors M; Karlson BW; Luepker R; Holmberg S; Swedberg K; Hjalmarsson A
    J Intern Med Suppl; 1991; 734():43-51. PubMed ID: 1900012
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of recombinant tissue-type plasminogen activator thrombolysis and primary coronary stenting after acute myocardial infarction.
    Chen B; Wang W; Zhao H; Hu D; Xu C; Zhao M; Lu M; Liu J; Wu C
    Chin Med J (Engl); 2003 Jan; 116(1):142-4. PubMed ID: 12667408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Left ventricular function after late thrombolysis with alteplase in myocardial infarction.
    Gil VM; Ventosa A; Antunes AF; Morais J; Seabra-Gomes R
    Rev Port Cardiol; 1996 May; 15(5):413-20, 366. PubMed ID: 8763515
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The safety and efficacy of systemic salvage thrombolysis in acute myocardial infarct].
    Sarullo FM; Schicchi R; Schirò M; Americo L; Bonnì G; Faraone N; Di Pasquale P; Castello A; Mauri F
    Ital Heart J Suppl; 2000 Jan; 1(1):81-7. PubMed ID: 10832123
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Limitation of myocardial infarction by early infusion of recombinant tissue-type plasminogen activator.
    O'Rourke M; Baron D; Keogh A; Kelly R; Nelson G; Barnes C; Raftos J; Graham K; Hillman K; Newman H
    Circulation; 1988 Jun; 77(6):1311-5. PubMed ID: 3131040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.